Status:
COMPLETED
Reducing the Need for In-Clinic Follow-Up for Medical Abortion in Moldova and Uzbekistan
Lead Sponsor:
Gynuity Health Projects
Conditions:
Medical Abortion, Fetus
Eligibility:
FEMALE
16-55 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine whether an alternative method of follow-up after medical abortion is acceptable and feasible for use in Moldova and Uzbekistan.
Detailed Description
Medical abortion using mifepristone and misoprostol is a highly effective procedure, but access to it may be impeded by the fact that not all women can afford or want to return for a follow-up visit. ...
Eligibility Criteria
Inclusion
- Reproductive-age woman seeking a medical abortion
- Woman in good general health
- Woman with an intrauterine pregnancy less than or equal to 63 days gestation on the day of mifepristone administration
- Woman able and willing to sign consent forms
- Woman eligible for medical abortion according to clinician's assessment
- Woman agreeing to be followed up with, by phone or at a clinic visit
Exclusion
- Woman with a pregnancy greater than 63 days gestation on the day of mifepristone administration
Key Trial Info
Start Date :
September 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2012
Estimated Enrollment :
2400 Patients enrolled
Trial Details
Trial ID
NCT01410266
Start Date
September 1 2010
End Date
October 1 2012
Last Update
December 3 2012
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
The Perinatalogy Center
Bălţi, Moldova
2
Municipal Clinical Hospital
Chisinau, Moldova
3
The National Center of Reproductive Health and Medical Genetics
Chisinau, Moldova
4
The Center of Women Health "Ana"
Drochia, Moldova